Human umbilical cord mesenchymal stem cells therapy (Shanghai Ixcell Biotechnology)

人脐带间充质干细胞疗法 (上海爱萨尔生物科技)

Report date: 2026/03/19 20:00:18

Base Information

Drug NameHuman umbilical cord mesenchymal stem cells therapy (Shanghai Ixcell Biotechnology)
Drug Alias NameIxCell hUC-MSC-OIxCell hUC-MSC-PIxCell hUC-MSC-S
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapyCell and gene therapy > Cell therapy > Source of cells > Umbilical cord-derived
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsIschemic StrokeStrokeLung Diseases, Interstitial +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesShanghai Ixcell Biomedical Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesShanghai Ixcell Biomedical Co Ltd
Inactive CompaniesN/A
Active IndicationsIschemic StrokeStrokeLung Diseases, Interstitial +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A